Neurogenic Atrophy Simulating Facioscapulohumeral Dystrophy. A Dominant Form
Overview
Authors
Affiliations
Morpholino treatment improves muscle function and pathology of Pitx1 transgenic mice.
Pandey S, Lee Y, Yokota T, Chen Y Mol Ther. 2013; 22(2):390-396.
PMID: 24232919 PMC: 3916049. DOI: 10.1038/mt.2013.263.
Conditional over-expression of PITX1 causes skeletal muscle dystrophy in mice.
Pandey S, Cabotage J, Shi R, Dixit M, Sutherland M, Liu J Biol Open. 2012; 1(7):629-639.
PMID: 23125914 PMC: 3486706. DOI: 10.1242/bio.20121305.
Familial bulbospinal neuronopathy with optic atrophy: a distinct entity.
Paradiso G, Micheli F, Taratuto A, Parera I J Neurol Neurosurg Psychiatry. 1996; 61(2):196-9.
PMID: 8708690 PMC: 1073996. DOI: 10.1136/jnnp.61.2.196.
Creatine phosphokinase in facioscapulohumeral muscular dystrophy.
Hughes B Br Med J. 1971; 3(5772):464-5.
PMID: 5567771 PMC: 1800383. DOI: 10.1136/bmj.3.5772.464.
The nosology of the spinal muscular atrophies.
EMERY A J Med Genet. 1971; 8(4):481-95.
PMID: 4948374 PMC: 1469097. DOI: 10.1136/jmg.8.4.481.